Form 4: Elanco Animal Health Executive Receives Stock Options and Restricted Stock Units
SEC Form 4 Filing
Grace McArdle, EVP of Manufacturing and Quality at Elanco Animal Health, reports the acquisition of stock options and restricted stock units.
Summary
- Grace McArdle, an executive at Elanco Animal Health, filed a Form 4 detailing changes in beneficial ownership.
- On March 3, 2025, McArdle acquired 59,138 stock options with an exercise price of $11.31, vesting in three equal installments on March 3, 2026, March 3, 2027, and March 3, 2028, expiring on March 3, 2035.
- McArdle also acquired 28,184 restricted stock units, vesting in three equal installments on March 3, 2026, March 3, 2027, and March 3, 2028.
- Following these transactions, McArdle directly owns 80,395 shares of Elanco Animal Health stock and 59,138 derivative securities.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The granting of stock options and restricted stock units is a standard practice and generally viewed favorably as it aligns executive interests with shareholder value. There are no explicitly negative aspects presented in the document.
Positives
- The grant of stock options and restricted stock units to a key executive like Grace McArdle can be seen as an incentive to align her interests with the long-term success of Elanco Animal Health.
- The vesting schedule encourages continued service and commitment to the company's goals.
Industry Context
Executive compensation packages including stock options and restricted stock units are common in the animal health industry to attract and retain talent, aligning executive interests with shareholder value.
Comparison to Industry Standards
- Stock option grants are a typical component of executive compensation packages in publicly traded companies, including those in the animal health sector.
- Companies like Zoetis and Merck Animal Health also utilize stock options and restricted stock units as part of their executive compensation plans.
- The vesting schedules are also fairly standard, often spread over three to four years to incentivize long-term commitment.
Stakeholder Impact
- Shareholders may view the grant of stock options and restricted stock units positively, as it incentivizes the executive to work towards increasing shareholder value.
- Employees may see this as a positive sign, indicating the company's commitment to rewarding its leadership.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Date of transaction: Grant of stock options and restricted stock units. |
| 03/03/2026 | First vesting date for one-third of the restricted stock units and stock options. |
| 03/03/2027 | Second vesting date for one-third of the restricted stock units and stock options. |
| 03/03/2028 | Final vesting date for the remaining restricted stock units and stock options. |
| 03/03/2035 | Expiration date of the stock options. |
| 03/05/2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.